- Home
- DERM vs GLO Comparison
DERM vs GLO Comparison
Compare DERM & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- GLO
- Stock Information
- Founded
- DERM 2014
- GLO 2006
- Country
- DERM United States
- GLO United States
- Employees
- DERM N/A
- GLO N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- DERM Health Care
- GLO Finance
- Exchange
- DERM Nasdaq
- GLO Nasdaq
- Market Cap
- DERM 174.7M
- GLO 193.7M
- IPO Year
- DERM 2021
- GLO N/A
- Fundamental
- Price
- DERM $6.88
- GLO $4.99
- Analyst Decision
- DERM Strong Buy
- GLO
- Analyst Count
- DERM 2
- GLO 0
- Target Price
- DERM $10.00
- GLO N/A
- AVG Volume (30 Days)
- DERM 78.2K
- GLO 170.5K
- Earning Date
- DERM 05-20-2025
- GLO 01-01-0001
- Dividend Yield
- DERM N/A
- GLO 11.38%
- EPS Growth
- DERM N/A
- GLO N/A
- EPS
- DERM N/A
- GLO N/A
- Revenue
- DERM $56,134,000.00
- GLO N/A
- Revenue This Year
- DERM $29.83
- GLO N/A
- Revenue Next Year
- DERM $54.88
- GLO N/A
- P/E Ratio
- DERM N/A
- GLO N/A
- Revenue Growth
- DERM N/A
- GLO N/A
- 52 Week Low
- DERM $3.20
- GLO $4.08
- 52 Week High
- DERM $7.84
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- DERM 52.73
- GLO 57.50
- Support Level
- DERM $6.47
- GLO $4.98
- Resistance Level
- DERM $7.15
- GLO $5.06
- Average True Range (ATR)
- DERM 0.49
- GLO 0.08
- MACD
- DERM -0.09
- GLO 0.03
- Stochastic Oscillator
- DERM 37.25
- GLO 84.00
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.